Bureaucrats, editor, reviewer, Administrators
5,246
edits
PROTECT AF: Difference between revisions
Jump to navigation
Jump to search
→Subgroup Analysis: fmt
(add neurology) |
(→Subgroup Analysis: fmt) |
||
| Line 133: | Line 133: | ||
===Subgroup Analysis=== | ===Subgroup Analysis=== | ||
; HR with treatment in men was lower than that for women (p=0.03; all other interaction tests p>0.40). | |||
: For men, HR 0.32 (95% CI 0.13–0.77) | |||
: For women, HR 1.47 (95% CI 0.52–4.11) | |||
No other significant subgroup effects were seen (including age, CHADS2 score, type of AF, LAA size, LVEF). This did not change with the publication of the follow up data in 2013. | No other significant subgroup effects were seen (including age, CHADS2 score, type of AF, LAA size, LVEF). This did not change with the publication of the follow up data in 2013. | ||